EuGESMA is a COST Action (BM0801) established to form a network among European clinical and science groups who actively contribute to the understanding and integration of modern genomics technologies with the aim of translating these into a clinical environment for the benefit of MDS and AML.




Action Chair:     Professor Ken Mills (email)

Telephone:        +44 (0)28 9097 2786